Therapy of anti-GBM GN 244 Table 32. Symptoms involving the brain and nervous system are not always due to lupus. Lay summary, R Agca, S C Heslinga, S Rollefstad, M Heslinga, I B McInnes, M J L Peters, T K Kvien, See slide deck Patients with lupus are susceptible to urinary tract infections, most of which are caused by bacteria that normally live in our intestines. Since the original guidelines were published in 2008, followed by subsequent publication of specific recommendations for neuropsychiatric and renal disease, monitoring, and women’s health, “new data have emerged on treatment … Skin disease in lupus is initially treated with creams/ointments or hydroxychloroquine, with or without oral glucocorticoids. Published Online First 27 September 2011/Print January 2012 Read recommendation, Helen E Foster, Kirsten Minden, Daniel Clemente, Leticia Leon, Janet E McDonagh, Sylvia Kamphuis, Karin Berggren, Philomine van Pelt, Carine Wouters, Jennifer Waite-Jones, Rachel Tattersall, Ruth Wyllie, Simon R Stones, Alberto Martini, Tamas Constantin, Susanne Schalm, Berna Fidanci, Burak Erer, Erkan Dermikaya, Seza Ozen, Loreto Carmona J Pharmacol Pharmacother. Read recommendation Published online 3 October 2016 Below are some helpful diet guidelines to support a healthy gut microbiome and reduce inflammation: With a stable disease, a diet rich in polyunsaturated fatty acids and anti-inflammatory omega-3 fatty acids can help prevent inflammation. Read this recommendation Lay summary, Désirée van der Heijde, Sofia Ramiro, Robert Landewé, Xenofon Baraliakos, Filip Van den Bosch, Alexandre Sepriano, Andrea Regel, Adrian Ciurea, Hanne Dagfinrud, Maxime Dougados, Floris van Gaalen, Pál Géher, Irene van der Horst-Bruinsma, Robert D Inman, Merryn Jongkees, Uta Kiltz, Tore K Kvien, Pedro M Machado, Helena Marzo-Ortega, Anna Molto, Victoria Navarro-Compàn, Salih Ozgocmen, Fernando M Pimentel-Santos, John Reveille, Martin Rudwaleit, Jochen Sieper, Percival Sampaio-Barros, Dieter Wiek, Jürgen Braun Annals of the Rheumatic Diseases Published Online First: 03 July 2019. doi: 10.1136 / annrheumdis-2019-215672 Last published: 2018. Read recommendation Annals of the Rheumatic Diseases Published Online First : August 14, 2019. doi: 10.1136 / annrheumdis-2019 to 215,882 Annals of the Rheumatic Diseases Published Online First: 22 January, 2020 doi: 10.1136/annrheumdis-2019-216655 T +41 44 716 30 30 EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice EULAR Recommendations for the use of imaging in large vessel vasculitis in clinical practice Lay summary, P Mandl, V Navarro-Compán, L Terslev, P Aegerter, D van der Heijde, M A D'Agostino, X Baraliakos, S J Pedersen, A G Jurik, E Naredo, C Schueller-Weidekamm, U Weber, M C Wick, P A C Bakker, E Filippucci, P G Conaghan, M Rudwaleit, G Schett, J Sieper, S Tarp, H Marzo-Ortega, M Østergaard Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease affecting multiple organ systems that runs an unpredictable course and may present with a wide variety of clinical manifestations. Annals of the Rheumatic Diseases 2016;2016-210815 In 2019, the joint guidelines for the management of adult and pediatric lupus nephritis were updated by the European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA). Read SLRs, Pascal Richette, Michael Doherty, Eliseo Pascual, Victoria Barskova, Fabio Becce, Johann castaneda, Malcolm Coyfish, Sylvie Guillo, Tim Jansen, Hein Janssens, Frédéric Lioté, Christian D Mallen, George Nuki, Fernando Perez-Ruiz, José Pimentao, Leonardo Punzi, Anthony Pywel, Alexander K So, Anne-Kathrin Tausche, Till Uhlig, Jakub Zavada, Weiya Zhang, Florence Tubach, Thomas Bardin Lay summary, N Duru, M C van der Goes, J W G Jacobs, T Andrews, M Boers, F Buttgereit, N Caeyers, M Cutolo, S Halliday, J A P Da Silva, J R Kirwan, D Ray, J Rovensky, G Severijns, R Westhovens, J W J Bijlsma Classification of study quality 250 Table 36. Annals of the Rheumatic Diseases 2020;79:778-786. Read this recommendation, J Braun, R van den Berg, X Baraliakos, H Boehm, R Burgos-Vargas, E Collantes-Estevez, H Dagfinrud, B Dijkmans, M Dougados, P Emery, P Geher, M Hammoudeh, RD Inman, M Jongkees, MA Khan, U Kiltz, TK Kvien, M Leirisalo-Repo, WP Maksymowych, I Olivieri, K Pavelka, J Sieper, E Stanislawska-Biernat, D Wendling, S Özgocem, C van Drogen, BJ van Royen, D Van der Heijde Read recommendation See Lay Summary, Maria G Tektonidou, Laura Andreoli, Marteen Limper, Zahir Amoura, Ricard Cervera, Nathalie Costedoat-Chalumeau, Maria Jose Cuadrado, Thomas Dörner, Raquel Ferrer-Oliveras, Karen Hambly, Munther A Khamashta, Judith King, Francesca Marchiori, Pier Luigi Meroni, Marta Mosca, Vittorio Pengo, Luigi Raio, Guillermo Ruiz-Irastorza, Yehuda Shoenfeld, Lyudmila Stojanovich, Elisabet Svenungsson, Denis Wahl, Angela Tincani, Michael M Ward Read SLRs EULAR Recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other inflammatory joint diseases - 2014/15 Update Annals of the Rheumatic Diseases 2017;76:948-959 Ann Rheum Dis doi:10.1136/annrheumdis-2016-209724 Clinical Practice Guidelines. Hydroxychloroquine is recommended in all patients with lupus, at a dose not exceeding 5 mg/kg real body weight. Read this recommendation See slide deck, Lisa Ehlers, Johan Askling, Hans WJ Bijlsma, Maria Cinta Cid, Maurizio Cutolo, Bhaskar Dasgupta, Christian Dejaco, William G Dixon, Nils Feltelius, Axel Finckh, Kate Gilbert, Sarah Louise Mackie, Alfred Mahr, Eric L Matteson, Lorna Neill, Carlo Salvarani, Wolfgang A Schmidt, Anja Strangfeld, Ronald F van Vollenhoven, Frank Buttgereit Published online first: 28 August 2018 Close monitoring of disease activity and patient adherence to treatment are recommended to help reduce the risk for flare. The bacteria that cause urinary tract infections may trigger lupus flares, a former Alzheimer’s disease therapy has shown promising results in research models—these are just some of the findings presented by Lupus Research Alliance-funded scientists at the 13 th International Congress on Systematic Lupus Erythematosus (LUPUS 2019), held in San Francisco. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. I am now aged 26, living life without any signs of lupus activity.” Annals of the Rheumatic Diseases 2016;75:965-973 There are national and international clinical practice guidelines for systemic lupus erythematosus treatment. Lay summary, Josef S Smolen, Robert Landewé, Ferdinand C Breedveld, Maya Buch, Gerd Burmester, Maxime Dougados, Paul Emery, Cécile Gaujoux-Viala, Laure Gossec, Jackie Nam, Sofia Ramiro, Kevin Winthrop, Maarten de Wit, Daniel Aletaha, Neil Betteridge, Johannes W J Bijlsma, Maarten Boers, Frank Buttgereit, Bernard Combe, Maurizio Cutolo, Nemanja Damjanov, Johanna M W Hazes, Marios Kouloumas, Tore K Kvien, Xavier Mariette, Karel Pavelka, Piet L C M van Riel, Andrea Rubbert-Roth, Marieke Scholte-Voshaar, David L Scott, Tuulikki Sokka-Isler, John B Wong, Désirée van der Heijde They release large amounts of damaging molecules known as reactive oxygen species and produce less energy. 2016 update of the EULAR recommendations for management of early arthritis Published Online First 28 October 2011 Read this recommendation Among the recommendations, high risk individuals who carry the antiphospholipid antibody should take low-dose aspirin, even if they are asymptomatic. Ann Rheum Dis doi:10.1136/annrheumdis-2015-208690 Results from a team led by Dr. Mariana Kaplan of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), also point to a possible treatment for lupus—a drug originally developed as a therapy for Alzheimer’s disease. Contacts, Legal disclaimer Published Online First: 06 March 2017 In lupus, the immune system attacks patients’ own tissues. Read recommendation Cutaneous lupus erythematosus is classified into acute, subacute, chronic and intermittent lupus erythematosus [11, 12]. Annals of the Rheumatic Diseases Published Online First: 31 October 2019. doi: 10.1136/annrheumdis-2019-216114 Lupus May Impair the Lymphatic System Read recommendation treatment in patients with lupus nephritis has not been as thoroughly examined. The American College of Rheumatology offers screening, treatment and management guidelines for lupus nephritis patients. First published March 16, 2016 Cope, O. Lambotte, J.E. By the age of 21, I weaned off my meds and put lupus in remission. The medications most commonly used to control lupus include: 1. April 11, 2019. Ann Rheum Dis doi:10.1136/ard.2011.150193 The scientists found that levels of antibodies that target curli were higher among people with lupus than among those without the disease. Ann Rheum Dis doi:10.1136/annrheumdis-2012-203158 When the inflammation was in its early stages, the flow of lymphatic fluid from the ears surged in all of the animals, whether they had lupus or not. Ann Rheum Dis doi:10.1136/annrheumdis-2015-208337 Read recommendation Federal Tax ID #58-2492929. Meissner Y, Fischer-Betz R, Andreoli L, et al There are now, in addition to standard calcium and vitamin D preparations, modern effective drugs for the prevention and treatment of osteoporosis. Published online First: 17 February 2017 Read recommendation, A Baillet, L Gossec, L Carmona, M de Wit, Y van Eijk-Hustings, H Bertheussen, A Kent, M Toft, M Kouloumas, R J O Ferreira, S Oliver, A Rubbert-Roth, S van Assen, W G Dixon, A Finckh, A Zink, J Kremer, T K Kvien, M Nurmohamed, D van der Heijde, M Dougados To summarize, the new guidelines recommend the following: “Treatment in SLE aims at remission or low disease activity and prevention of flares. EULAR recommendations for calcium pyrophosphate deposition. Points to consider for the development, evaluation and implementation of mobile health applications for self-management in patients with rheumatic diseases Read recommendation Dubey AK, Handu SS, Dubey S, et al. F +41 44 716 30 39 Ann Rheum Dis 2012;71:4-12 doi:10.1136/annrheumdis-2011-200350  2019 update of the EULAR recommendations for the management of systemic lupus erythematosus March 2019 Annals of the Rheumatic Diseases 78(6):annrheumdis-2019-215089 Published Online First: 13 January 2017 Lupus News Today is strictly a news and information website about the disease. In this slideshow, we highlight a few of the achievements made throughout the year. During chronic maintenance treatment, glucocorticoids (GC) should be minimised to less than 7.5 mg/day (prednisone equivalent) and, when possible, withdrawn. Whitney J. Palmer. Slide deck, Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, Jackie Nam, Sofia Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Chris D Buckley, Frank Buttgereit, Vivian Bykerk, Mario Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk-Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan Gomez-Reino, Laure Gossec, Jacques-Eric Gottenberg, Johanna M W Hazes, Tom Huizinga, Meghna Jani, Dmitry Karateev, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain McInnes, Eduardo Mysler, Peter Nash, Karel Pavelka, Gyula Poór, Christophe Richez, Piet van Riel, Andrea Rubbert-Roth, Kenneth Saag, Jose da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde These recommendations were “developed by a large group of physicians from different specialties and nurses caring for LN, with input from patients, and complement the recently updated … 2018 Update of the EULAR recommendations for the management of large vessel vasculitis see slide deck presentation, P Mandl, V Navarro-Compán, L Terslev, P Aegerter, D van der Heijde, M A D'Agostino, X Baraliakos, S J Pedersen, A G Jurik, E Naredo, C Schueller-Weidekamm, U Weber, M C Wick, P A C Bakker, E Filippucci, P G Conaghan, M Rudwaleit, G Schett, J Sieper, S Tarp, H Marzo-Ortega, M Østergaard EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update The results could help researchers design new treatments for lupus nephritis, the kidney inflammation that affects about half of patients with the disease. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that causes inflammation in connective tissues, such as cartilage and the lining of blood vessels, … It is a chronic condition that can affect multiple tissues and organs. RMD Open 2018;4:e000612. see the slide presentation here, M Yates, R A Watts, I M Bajema, M C Cid, B Crestani, T Hauser, B Hellmich, J U Holle, M Laudien, M A Little, R A Luqmani, A Mahr, P A Merkel, J Mills, J Mooney, M Segelmark, V Tesar, K Westman, A Vaglio, N Yalçındağ, D R Jayne, C Mukhtyar These attacks may occur because the tissues carry molecules that resemble the molecules of certain bacteria. Each authors lists the following: The authors, the title, the publication citation, publication date and link to the final, published recommendation text. Ann Rheum Dis doi:10.1136/annrheumdis-2012-202745  Annals of the Rheumatic Diseases Published Online First: 05 June 2020. doi: 10.1136/annrheumdis-2020-217877 The scientists found more kinds of immune cells in the kidneys than they expected. Lay Summary, Manuel Ramos-Casals, Pilar Brito-Zerón, Stefano Bombardieri, Hendrika Bootsma, Salvatore De Vita, Thomas Dörner, Benjamin A Fisher, Jacques-Eric Gottenberg, Gabriela Hernandez-Molina, Agnes Kocher, Belchin Kostov, Aike A. Kruize, Thomas Mandl, Wan-Fai Ng, Soledad Retamozo, Raphaèle Seror, Yehuda Shoenfeld, Antoni Sisó-Almirall, Athanasios G. Tzioufas, Claudio Vitali, Simon Bowman, Xavier Mariette 2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis It does not provide medical advice, diagnosis or treatment. See slide deck Read SLR Hydroxychloroquine is recommended in all patients with lupus, at a dose not exceeding 5 standardised operating proceduresmg/kg real body weight. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis Arthritis Care Res (Hoboken) . This week, at the American College of Rheumatology (ACR) Annual Scientific Meeting, several pharmaceutical companies have shared exciting treatment news. Brunner H, Abud-Mendoza C, Viola D, et al. Read recommendation, Laure Gossec Xenofon Baraliakos, Andreas Kerschbaumer, Maarten de Wit, Iain McInnes, Maxime Dougados, Jette Primdahl, Dennis G McGonagle, Daniel Aletaha, Andra Balanescu, Peter V Balint, Heidi Bertheussen, Wolf-Henning Boehncke, Gerd R Burmester, Juan D Canete, Nemanja S Damjanov, Tue Wenzel Kragstrup, Tore K Kvien, Robert B M Landewé, Rik Jozef Urbain Lories, Helena Marzo-Ortega, Denis Poddubnyy, Santiago Andres Rodrigues Manica, Georg Schett, Douglas J Veale, Filip E Van den Bosch, Désirée van der Heijde, Josef S Smolen Screening criteria for systematic review topics of nontreatment and treatment 248 Table 33. Here are some of their discoveries. April 11, 2019. for the management of systemic lupus … “Luckily, my medication worked better than imagined. Identifying Genes Responsible for High Interferon Levels 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus [published online March 29, 2019… To find out whether curli had the same effect in people, the researchers obtained blood samples from patients with lupus at the Temple Lupus Clinic and tested them for antibodies, defensive molecules produced by the immune system. A G Semb, G D Kitas, Y M Smulders, Z Szekanecz, N Sattar, D P M Symmons, Annals of the Rheumatic Diseases 2017;76:802-810 Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis New: 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus . Annals of the Rheumatic Diseases Published Online First: 29 March 2019. doi: 10.1136 / annrheumdis-2019-215089 Annals of the Rheumatic Diseases 2018; 10.1136/annrheumdis-2018-213225 European League Against Rheumatism, EULAR has released its 2019 guidelines and recommendations for the management of systemic lupus erythematosus (SLE).They have appeared in Annals of Rheumatic Diseases. New Guidelines for Lupus Treatment From EULAR, Updates in Lupus Clinical Research from the LUPUS 2019 Meeting. Read recommendation The lymphatic system has an important effect on the immune system because it helps control inflammation and the activities of immune cells. M T Nurmohamed See slide deck EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors doi: 10.1136/rmdopen-2017-000612                                   Published online first: 2 February 2018 Clinical Practice Guidelines Systemic Lupus Erythematosus Search this Guide Search. Read recommendation, G J Macfarlane, C Kronisch, L E Dean, F Atzeni, W Häuser, E Fluß, E Choy, E Kosek, K Amris, J Branco, F Dincer, P Leino-Arjas, K Longley, G M McCarthy, S Makri, S Perrot, P Sarzi-Puttini, A Taylor, G T Jones Hydroxychloroquine is recommended in all patients with lupus, at a dose not exceeding 5 mg/kg real body weight. Read recommendation Published online first: 22 January 2018 Published online First: 10 March 2017 2016 Update of EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease modifying antirheumatic drugs And of those with lupus, antibodies that recognize curli were more abundant in people who were undergoing flares. 2019;44(8)(Specialty&Oncology suppl)3-7. By the time a patient is diagnosed with SLE, nephritis has already set in for 35 percent of patients. Read SLR doi: 10.1136/annrheumdis-2016-210715 Ann Rheum Dis 2011;70:571-575 Ann Rheum Dis doi:10.1136/annrheumdis-2016-210770 Annals of the Rheumatic Diseases Published Online First: 05 June 2019. doi: 10.1136/annrheumdis-2019-215315 See slide deck medwireNews: EULAR has published up-to-date recommendations for the management of systemic lupus erythematosus (SLE) based on emerging evidence and expert opinion.. 2019 update of the EULAR recommendations for the ... Clinical practice guidelines for the treatment of systemic lupus erythematosus external link opens in a new window. Ann Rheum Dis 2015;74:1327-1339 doi:10.1136/annrheumdis-2014-206971 Lucio Zapata, Benjamin F. Chong, Exclusion of Cutaneous Lupus Erythematosus Subtypes From the 2019 European League Against Rheumatism/American College of Rheumatology Classifi cation Criteria for Systemic Lupus Erythematosus: Comment on the Article by Aringer et al, Arthritis & Rheumatology, 10.1002/art.41296, 72, 8, (1403-1404), (2020). EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis Over-the-counter NSAIDs, such as nap… 2019 EULAR Guidelines on Antiphospholipid Syndrome Management Save. Updates on the latest treatment news from ACR 2019. Whitney J. Palmer. First published September 13, 2019, RMD Open 2019;5:e001014. Read recommendation EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases European League Against Rheumatism, EULAR has released its 2019 guidelines and recommendations for the management of systemic lupus erythematosus (SLE).They have appeared in Annals of Rheumatic Diseases. Initial therapy with pulses of intravenous MP (1–3 days) is encouraged. Dr. Lu and her team used a blue dye to follow lymph movement in animal models with ear inflammation. Now, the researchers plan to focus on unraveling how each type of cell contributes to lupus nephritis. 234 Table 30. Reviving an Old Drug to Treat Lupus Read SLR's Idebenone neutralizes reactive oxygen species and can increase mitochondria’s power-generating ability. See slide deck, Margreet Kloppenburg, Féline PB Kroon, Francisco J Blanco, Michael Doherty, Krysia S Dziedzic, Elsie Greibrokk, Ida K Haugen, Gabriel Herrero-Beaumont, Helgi Jonsson, Ingvild Kjeken, Emmanuel Maheu, Roberta Ramonda, Marco JPF Ritt, Wilma Smeets, Josef S Smolen, Tanja A Stamm, Zoltan Szekanecz, Ruth Wittoek, Loreto Carmona A charitable organization with 501(c)(3) tax-exempt status. Annals of the Rheumatic Diseases 2020; 79 680-682 Published Online First: 20 May 2020. doi: 10.1136/annrheumdis-2020-217236 Scroll to the bottom of the page to start the year 2000, scrolling upwards through the years to the present day. Hua, D. Aletaha, J. M. Álvaro-Gracia, M. Bakkers, N. Brodin, G R Burmester, C Codreanu, R Conway, M Dougados, P Emery, G. Ferraccioli, J. Fonseca, K. Raza, L. Silva-Fernández, J. All rights reserved. Bingham, K. Visser, J. Leipe, H. Schulze-Koops, E. Choy K. Benesova, T.R. Read recommendation ... managing cardiovascular and venous thrombosis risk factors, patient education about treatment adherence, and lifestyle counselling. Our guidelines grow out of the collaborative efforts of many members and non-members, specialists and generalists, patients and carers. On Friday 6 th October 2017, during Lupus Awareness Month, the British Society for Rheumatology (BSR) published the first UK guideline on the care of adults with systemic lupus erythematosus (lupus). Ann Rheum Dis doi:10.1136/annrheumdis-2016-209133 Because less fluid is draining from the animals’ ears, molecules produced by immune cells might become trapped and continue to spur inflammation. 2018 update of the EULAR recommendations for the management of hand osteoarthritis Ann Rheum Dis doi:10.1136/annrheumdis-2016-209775 Lay summary Published Online First: 20 January 2011 Hahn BH, McMahon MA, Wilkinson A, et al. Lucio Zapata, Benjamin F. Chong, Exclusion of Cutaneous Lupus Erythematosus Subtypes From the 2019 European League Against Rheumatism/American College of Rheumatology Classifi cation Criteria for Systemic Lupus Erythematosus: Comment on the Article by Aringer et al, Arthritis & Rheumatology, 10.1002/art.41296, 72, 8, (1403-1404), (2020). EULAR Data Protection Policy, Heidi A Zangi, Mwidimi Ndosi, Jo Adams, Lena Andersen, Christina Bode, Carina Boström, Yvonne van Eijk-Hustings, Laure Gossec, Jana Korandová, Gabriel Mendes, Karin Niedermann, Jette Primdahl, Michaela Stoffer, Marieke Voshaar, Astrid van Tubergen, EULAR Annual European Congress of Rheumatology, Classification and response criteria/diagnostic approaches, Recommendations for conducting/reporting clinical trials, PARE (People with Arthritis and Rheumatism), European Parliament Interest Group on RMDs, Download the EULAR 2016 Congress presentation, Otylia Kowal-Bielecka, Jaap Fransen, Jerome Avouac, Mike Becker, Agnieszka Kulak, Yannick Allanore, Oliver Distler, Philip Clements, Maurizio Cutolo, Laszlo Czirjak, Nemanja Damjanov, Francesco del Galdo, Christopher P Denton, Jörg H W Distler, Ivan Foeldvari, Kim Figelstone, Marc Frerix, Daniel E Furst, Serena Guiducci, Nicolas Hunzelmann, Dinesh Khanna, Marco Matucci-Cerinic, Ariane L Herrick, Frank van den Hoogen, Jacob M van Laar, Gabriela Riemekasten, Richard Silver, Vanessa Smith, Alberto Sulli, Ingo Tarner, Alan Tyndall, Joep Welling, Frederic Wigley, Gabriele Valentini, Ulrich A Walker, Francesco Zulian, Ulf Müller-Ladner, Christian Dejaco, Yogesh P Singh, Pablo Perel, Andrew Hutchings, Dario Camellino, Sarah Mackie, Andy Abril, Artur Bachta, Peter Balint, Kevin Barraclough, Lina Bianconi, Frank Buttgereit, Steven Carsons, Daniel Ching, Maria Cid, Marco Cimmino, Andreas Diamantopoulos, William Docken, Christina Duftner, Billy Fashanu, Kate Gilbert, Pamela Hildreth, Jane Hollywood, David Jayne, Manuella Lima, Ajesh Maharaj, Christian Mallen, Victor Martinez-Taboada, Mehrdad Maz, Steven Merry, Jean Miller, Shunsuke Mori, Lorna Neill, Elisabeth Nordborg, Jennifer Nott, Hannah Padbury, Colin Pease, Carlo Salvarani, Michael Schirmer, Wolfgang Schmidt, Robert Spiera, David Tronnier, Alexandre Wagner, Madeline Whitlock, Eric L Matteson, Bhaskar Dasgupta.